Reata Pharmaceuticals Inc (NASDAQ:RETA)

Delayed Data
As of Mar 24
 -2.28 / -2.59%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 105.00, with a high estimate of 198.00 and a low estimate of 75.00. The median estimate represents a +22.56% increase from the last price of 85.67.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.33%
Growthannually -4.19%


Growthquarterly -30.16%
Growthannually -78.74%
Key to the earnings and sales forecast charts.